Pledge Therapeutics
PrivateLast Round
Follow-on Offering
Apr 17, 2026
Total Funding Raised
$42.9M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Pledge Therapeutics is a biotechnology company that develops small-molecule drugs for challenging disease targets in immuno-oncology and antiviral research.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Foundation
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pledge Therapeutics Comparables
Compare Pledge Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nimbus Therapeutics | 77% | |
| Recursion Pharmaceuticals | 76% | |
| Eli Lilly and Company | 74% |
Pledge Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Follow-on Offering | Apr 17, 2026 | ||||
| VC Round | Dec 10, 2024 | ||||
| Seed | Apr 3, 2024 | ||||
| Early Funding | Jul 24, 2023 | ||||
| Angel | Nov 8, 2021 | ||||
Series A | Mar 8, 2018 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
$11M raised in follow-on offering.
- Apr 4, 2026
Grew 17% QoQ, from 24 to 28 employees.
Pledge Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Pledge Therapeutics's valuation, stock price, and market status.
Is Pledge Therapeutics a public or private company?
Pledge Therapeutics is a private company.
What is the current stock price of Pledge Therapeutics?
Pledge Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Pledge Therapeutics worth (valuation)?
Valuation information for Pledge Therapeutics is not publicly available.
Can I buy Pledge Therapeutics stock?
Pledge Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Pledge Therapeutics's last funding round?
Pledge Therapeutics's most recent funding round was Follow-on Offering on April 17, 2026.
Who are the main investors in Pledge Therapeutics?
Investor information for Pledge Therapeutics is not publicly disclosed.
Will Pledge Therapeutics IPO soon?
No public IPO plans have been announced for Pledge Therapeutics.
How can I track Pledge Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Pledge Therapeutics's secondary market activity and sign up for updates.